Michael Ryskin
Stock Analyst at Bank of America Securities
(4.50)
# 1,113
Out of 5,128 analysts
714
Total ratings
59.6%
Success rate
6.2%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALGN Align Technology | Reiterated: Sell | n/a | $166.97 | - | 26 | Nov 9, 2026 | |
| MTD Mettler-Toledo International | Reiterated: Buy | $1,690 | $1,730.93 | -2.36% | 14 | Nov 6, 2026 | |
| ALMR Alamar Biosciences | Reiterated: Hold | n/a | $31.76 | - | 3 | Nov 4, 2026 | |
| CRL Charles River Laboratories International | Reiterated: Buy | n/a | $340.81 | - | 20 | Sep 28, 2026 | |
| A Agilent Technologies | Reiterated: Buy | $155 → $180 | $173.01 | +4.04% | 25 | Aug 27, 2026 | |
| PAHC Phibro Animal Health | Reiterated: Sell | $35 | $35.46 | -1.30% | 16 | Aug 27, 2026 | |
| IDXX IDEXX Laboratories | Reiterated: Hold | $660 → $665 | $698.02 | -4.73% | 33 | Aug 14, 2026 | |
| ELAN Elanco Animal Health | Reiterated: Buy | $32 → $34 | $26.50 | +28.30% | 36 | Aug 12, 2026 | |
| TXG 10x Genomics | Reiterated: Hold | n/a | $59.10 | - | 28 | Aug 7, 2026 | |
| CAI Caris Life Sciences | Reiterated: Buy | n/a | $23.96 | - | 9 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $30.85 | - | 23 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $60.33 | - | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $140 | $209.55 | -33.19% | 48 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.36 | - | 14 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $400 → $415 | $462.20 | -10.21% | 21 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 | $232.16 | -0.93% | 41 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $3.2 | $5.68 | -43.66% | 11 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $64 → $52 | $75.89 | -31.48% | 18 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $154.86 | - | 19 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $20.06 | - | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $150 → $160 | $200.51 | -20.20% | 22 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $320 → $360 | $372.32 | -3.31% | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 → $280 | $271.11 | +3.28% | 18 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $82.96 | - | 44 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 → $265 | $259.65 | +2.06% | 17 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $410 | $411.30 | -0.32% | 17 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $630 → $650 | $699.44 | -7.07% | 30 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2.4 | $1.66 | +44.58% | 10 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 → $16 | $16.54 | -3.26% | 14 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $157.02 | - | 17 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 → $49 | $50.10 | -2.20% | 16 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $11 | $15.62 | -29.58% | 21 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $8 | $7.68 | n/a | 13 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $17 | $11.90 | n/a | 12 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $10 | $10.23 | n/a | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $10 → $2.4 | $9.14 | n/a | 3 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $31 → $10 | $3.33 | n/a | 2 | Apr 18, 2022 |
Align Technology
Nov 9, 2026
Reiterated: Sell
Price Target: n/a
Current: $166.97
Upside: -
Mettler-Toledo International
Nov 6, 2026
Reiterated: Buy
Price Target: $1,690
Current: $1,730.93
Upside: -2.36%
Alamar Biosciences
Nov 4, 2026
Reiterated: Hold
Price Target: n/a
Current: $31.76
Upside: -
Charles River Laboratories International
Sep 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $340.81
Upside: -
Agilent Technologies
Aug 27, 2026
Reiterated: Buy
Price Target: $155 → $180
Current: $173.01
Upside: +4.04%
Phibro Animal Health
Aug 27, 2026
Reiterated: Sell
Price Target: $35
Current: $35.46
Upside: -1.30%
IDEXX Laboratories
Aug 14, 2026
Reiterated: Hold
Price Target: $660 → $665
Current: $698.02
Upside: -4.73%
Elanco Animal Health
Aug 12, 2026
Reiterated: Buy
Price Target: $32 → $34
Current: $26.50
Upside: +28.30%
10x Genomics
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $59.10
Upside: -
Caris Life Sciences
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $23.96
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $30.85
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $60.33
Upside: -
Aug 5, 2026
Reiterated: Sell
Price Target: $140
Current: $209.55
Upside: -33.19%
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $14.36
Upside: -
Aug 4, 2026
Reiterated: Hold
Price Target: $400 → $415
Current: $462.20
Upside: -10.21%
Aug 3, 2026
Reiterated: Buy
Price Target: $230
Current: $232.16
Upside: -0.93%
Aug 3, 2026
Reiterated: Sell
Price Target: $4 → $3.2
Current: $5.68
Upside: -43.66%
Aug 3, 2026
Reiterated: Hold
Price Target: $64 → $52
Current: $75.89
Upside: -31.48%
Jul 31, 2026
Reiterated: Buy
Price Target: n/a
Current: $154.86
Upside: -
Jul 30, 2026
Reiterated: Sell
Price Target: n/a
Current: $20.06
Upside: -
Jul 30, 2026
Reiterated: Sell
Price Target: $150 → $160
Current: $200.51
Upside: -20.20%
Jul 30, 2026
Reiterated: Buy
Price Target: $320 → $360
Current: $372.32
Upside: -3.31%
Jul 28, 2026
Reiterated: Buy
Price Target: $245 → $280
Current: $271.11
Upside: +3.28%
Jul 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $82.96
Upside: -
Jul 24, 2026
Reiterated: Buy
Price Target: $245 → $265
Current: $259.65
Upside: +2.06%
Jul 24, 2026
Reiterated: Buy
Price Target: $410
Current: $411.30
Upside: -0.32%
Jul 23, 2026
Reiterated: Buy
Price Target: $630 → $650
Current: $699.44
Upside: -7.07%
Jul 15, 2026
Reiterated: Sell
Price Target: $2.4
Current: $1.66
Upside: +44.58%
Jul 13, 2026
Reiterated: Hold
Price Target: $11 → $16
Current: $16.54
Upside: -3.26%
May 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $157.02
Upside: -
May 13, 2026
Reiterated: Buy
Price Target: $56 → $49
Current: $50.10
Upside: -2.20%
Feb 11, 2026
Reiterated: Hold
Price Target: $13 → $11
Current: $15.62
Upside: -29.58%
Mar 3, 2025
Reiterated: Buy
Price Target: $9 → $8
Current: $7.68
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $15 → $17
Current: $11.90
Upside: n/a
Jul 18, 2024
Reiterated: Sell
Price Target: $10
Current: $10.23
Upside: n/a
Apr 24, 2023
Reiterated: Sell
Price Target: $10 → $2.4
Current: $9.14
Upside: n/a
Apr 18, 2022
Downgraded: Hold
Price Target: $31 → $10
Current: $3.33
Upside: n/a